Coalition for reducing bureaucracy in clinical trials
In September 2020 a broad cross-disciplinary coalition of medical societies [...]
ASCO GU 2023: How do patients around the world experience kidney cancer?
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
Quality of life reporting in kidney cancer clinical trials
Quality-of-life (QoL) is very important to patients when they are [...]
Cancer clinical trial recruitment drops by 60% during the pandemic
Hospital Pharmacy Europe reported that the number of cancer patients [...]
First patient enrolled in renal cell carcinoma liquid biopsy trial
The first patient has been enrolled in the AURORAX-087A study [...]
What to expect: Enrolling on a cancer clinical trial during the COVID-19 pandemic
The COVID-19 pandemic has resulted in a number of changes [...]
How the coronavirus pandemic may affect cancer clinical trials
In this article published in Cancer Therapy Advisor this week, [...]
Clinical research cut by 87% at peak of COVID-19 pandemic
Research from University College London published in PLOS One estimated [...]
ASCO GU 2020: Randomised clinical trial of HIF-2α inhibitor in patients with advanced kidney cancer
A randomised clinical trial of hypoxia inducible factor 2α (HIF-2α) [...]
Real world use of targeted therapies in war veterans with kidney cancer
A retrospective study of the use of targeted therapies for [...]
